Theresa L Davis

Array ( [id] => 668532 [patent_doc_number] => 07094773 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-08-22 [patent_title] => 'LTA4 hydrolase inhibitors' [patent_app_type] => utility [patent_app_number] => 10/900384 [patent_app_country] => US [patent_app_date] => 2004-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11162 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/094/07094773.pdf [firstpage_image] =>[orig_patent_app_number] => 10900384 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7011658 [patent_doc_number] => 20050065342 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-24 [patent_title] => 'Quinoxaline derivatives, and light emitting element using thereof' [patent_app_type] => utility [patent_app_number] => 10/900781 [patent_app_country] => US [patent_app_date] => 2004-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 10298 [patent_no_of_claims] => 108 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0065/20050065342.pdf [firstpage_image] =>[orig_patent_app_number] => 10900781 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7026787 [patent_doc_number] => 20050020594 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-27 [patent_title] => 'Substituted pyridazinones' [patent_app_type] => utility [patent_app_number] => 10/893073 [patent_app_country] => US [patent_app_date] => 2004-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34744 [patent_no_of_claims] => 86 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20050020594.pdf [firstpage_image] =>[orig_patent_app_number] => 10893073 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5596893 [patent_doc_number] => 20060160811 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-20 [patent_title] => 'Aryl-condensed 3-arylpridine compounds and use thereof for controlling pathogenic fungi' [patent_app_type] => utility [patent_app_number] => 10/563222 [patent_app_country] => US [patent_app_date] => 2004-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21192 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20060160811.pdf [firstpage_image] =>[orig_patent_app_number] => 10563222 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 869143 [patent_doc_number] => 07365194 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-04-29 [patent_title] => 'Dimer of phenazine-1-carboxylic acid and to the process of preparation thereof' [patent_app_type] => utility [patent_app_number] => 10/888786 [patent_app_country] => US [patent_app_date] => 2004-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 4402 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/365/07365194.pdf [firstpage_image] =>[orig_patent_app_number] => 10888786 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1002542 [patent_doc_number] => 06908998 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-06-21 [patent_title] => 'Method of producing ultraviolet radiation absorbent' [patent_app_type] => utility [patent_app_number] => 10/882463 [patent_app_country] => US [patent_app_date] => 2004-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10561 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 155 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/908/06908998.pdf [firstpage_image] =>[orig_patent_app_number] => 10882463 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6906209 [patent_doc_number] => 20050101604 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-12 [patent_title] => 'Certain heterocyclic substituted imidazo[1,2-A]pyrazin-8-ylamines and methods of inhibition of bruton\'s tyrosine kinase by such compounds' [patent_app_type] => utility [patent_app_number] => 10/883646 [patent_app_country] => US [patent_app_date] => 2004-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14801 [patent_no_of_claims] => 63 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0101/20050101604.pdf [firstpage_image] =>[orig_patent_app_number] => 10883646 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7276395 [patent_doc_number] => 20040235846 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-25 [patent_title] => 'Substituted nicotinamides and analogs as activators of caspases and inducers of apoptosis and the use thereof' [patent_app_type] => new [patent_app_number] => 10/876618 [patent_app_country] => US [patent_app_date] => 2004-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 19037 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0235/20040235846.pdf [firstpage_image] =>[orig_patent_app_number] => 10876618 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7105310 [patent_doc_number] => 20050107391 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-19 [patent_title] => 'Arylmethyl triazolo-and imidazopyrazines as c-Met inhibitors' [patent_app_type] => utility [patent_app_number] => 10/875507 [patent_app_country] => US [patent_app_date] => 2004-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16419 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0107/20050107391.pdf [firstpage_image] =>[orig_patent_app_number] => 10875507 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 497498 [patent_doc_number] => 07208494 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-04-24 [patent_title] => '5HT2c receptor agonists' [patent_app_type] => utility [patent_app_number] => 10/876954 [patent_app_country] => US [patent_app_date] => 2004-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 42904 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/208/07208494.pdf [firstpage_image] =>[orig_patent_app_number] => 10876954 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 695319 [patent_doc_number] => 07071180 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-07-04 [patent_title] => 'Certain arylaliphatic and heteroaryl-aliphatic piperazinyl pyrazines and their use in the treatment of serotonin-related diseases' [patent_app_type] => utility [patent_app_number] => 10/873852 [patent_app_country] => US [patent_app_date] => 2004-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 47179 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/071/07071180.pdf [firstpage_image] =>[orig_patent_app_number] => 10873852 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7276398 [patent_doc_number] => 20040235849 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-25 [patent_title] => 'Tetrahydroquinoxalines acting as bradykinin antagonists' [patent_app_type] => new [patent_app_number] => 10/483464 [patent_app_country] => US [patent_app_date] => 2004-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16799 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0235/20040235849.pdf [firstpage_image] =>[orig_patent_app_number] => 10483464 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7603370 [patent_doc_number] => 07235662 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-06-26 [patent_title] => 'Modulators of the glucocorticoid receptor and method' [patent_app_type] => utility [patent_app_number] => 10/865444 [patent_app_country] => US [patent_app_date] => 2004-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20457 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/235/07235662.pdf [firstpage_image] =>[orig_patent_app_number] => 10865444 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 798050 [patent_doc_number] => 07427637 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-09-23 [patent_title] => 'Mitotic kinesin inhibitors' [patent_app_type] => utility [patent_app_number] => 10/559855 [patent_app_country] => US [patent_app_date] => 2004-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24690 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/427/07427637.pdf [firstpage_image] =>[orig_patent_app_number] => 10559855 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6991462 [patent_doc_number] => 20050090499 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-28 [patent_title] => 'Certain imidazo[1,2-a]pyrazin-8-ylamines and method of inhibition of bruton\'s tyrosine kinase by such compounds' [patent_app_type] => utility [patent_app_number] => 10/861791 [patent_app_country] => US [patent_app_date] => 2004-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24817 [patent_no_of_claims] => 87 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0090/20050090499.pdf [firstpage_image] =>[orig_patent_app_number] => 10861791 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5102065 [patent_doc_number] => 20070185327 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-09 [patent_title] => 'Preparation of substituted quinoxalines' [patent_app_type] => utility [patent_app_number] => 10/858600 [patent_app_country] => US [patent_app_date] => 2004-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1747 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0185/20070185327.pdf [firstpage_image] =>[orig_patent_app_number] => 10858600 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7027371 [patent_doc_number] => 20050020849 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-27 [patent_title] => 'Kinetic resolutions of chiral 2- and 3-substituted carboxylic acids' [patent_app_type] => utility [patent_app_number] => 10/854737 [patent_app_country] => US [patent_app_date] => 2004-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 23271 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20050020849.pdf [firstpage_image] =>[orig_patent_app_number] => 10854737 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 418835 [patent_doc_number] => 07276507 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-10-02 [patent_title] => 'Pyridopyrazines and the use thereof as kinase inhibitors' [patent_app_type] => utility [patent_app_number] => 10/851976 [patent_app_country] => US [patent_app_date] => 2004-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17058 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/276/07276507.pdf [firstpage_image] =>[orig_patent_app_number] => 10851976 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 917300 [patent_doc_number] => 07323468 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-01-29 [patent_title] => 'Pyridopyrazines and the use thereof as kinase inhibitors' [patent_app_type] => utility [patent_app_number] => 10/851966 [patent_app_country] => US [patent_app_date] => 2004-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11480 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/323/07323468.pdf [firstpage_image] =>[orig_patent_app_number] => 10851966 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7225090 [patent_doc_number] => 20050261312 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-24 [patent_title] => 'Pharmaceutically acceptable inorganic and organic salts of 5-methylpyrazine-2-carboxylic acid-4-oxide' [patent_app_type] => utility [patent_app_number] => 10/848098 [patent_app_country] => US [patent_app_date] => 2004-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2238 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0261/20050261312.pdf [firstpage_image] =>[orig_patent_app_number] => 10848098 [rel_patent_id] =>[rel_patent_doc_number] =>)